Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bodyl A Brand

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Schizophrenia Bulletin|March 21, 2026
Why Women With Psychosis Need Extra Attention-An Introduction to Special Theme Issue Women's Mental HealthBodyl A Brand, Iris E C Sommer
Current Opinion in Psychiatry|February 9, 2021
Estrogens in schizophrenia: progress, current challenges and opportunitiesBodyl A Brand, Janna N de Boer, Iris E C Sommer
The Lancet. Psychiatry|February 26, 2022
Towards better care for women with schizophrenia-spectrum disordersBodyl A Brand, Janna N de Boer, Paola Dazzan, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|January 12, 2024
Sex differences need to be considered when treating women with psychotropic drugsIris E Sommer, Bodyl A Brand, Clementine C M Stuijt, et al.
Schizophrenia Bulletin|October 5, 2022
Women with Schizophrenia-Spectrum Disorders After Menopause: A Vulnerable Group for RelapseIris E Sommer, Bodyl A Brand, Shiral Gangadin, et al.
Current Psychiatry Reports|October 21, 2023
Evidence-Based Recommendations for the Pharmacological Treatment of Women with Schizophrenia Spectrum DisordersBodyl A Brand, Elske J M Willemse, Iris M H Hamers, et al.
Psychological Medicine|October 19, 2020
Efficacy of non-invasive brain stimulation on cognitive functioning in brain disorders: a meta-analysisMarieke J Begemann, Bodyl A Brand, Branislava Ćurčić-Blake, et al.
Current Psychiatry Reports|July 18, 2024
Correction to: Evidence‑Based Recommendations for the Pharmacological Treatment of Women with Schizophrenia Spectrum DisordersBodyl A Brand, Elske J M Willemse, Iris M H Hamers, et al.
The American Journal of Psychiatry|September 12, 2024
Real-World Effectiveness of Menopausal Hormone Therapy in Preventing Relapse in Women With Schizophrenia or Schizoaffective DisorderBodyl A Brand, Iris E Sommer, Shiral S Gangadin, et al.
BMC Medicine|July 7, 2025
Do women need a change in dose of prescription drugs with onset of menopause? Time to find outIris E C Sommer, Bodyl A Brand, Tanja R Zijp, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Schizophrenia Bulletin|March 21, 2026
Why Women With Psychosis Need Extra Attention-An Introduction to Special Theme Issue Women's Mental HealthBodyl A Brand, Iris E C Sommer
Current Opinion in Psychiatry|February 9, 2021
Estrogens in schizophrenia: progress, current challenges and opportunitiesBodyl A Brand, Janna N de Boer, Iris E C Sommer
The Lancet. Psychiatry|February 26, 2022
Towards better care for women with schizophrenia-spectrum disordersBodyl A Brand, Janna N de Boer, Paola Dazzan, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|January 12, 2024
Sex differences need to be considered when treating women with psychotropic drugsIris E Sommer, Bodyl A Brand, Clementine C M Stuijt, et al.
Schizophrenia Bulletin|October 5, 2022
Women with Schizophrenia-Spectrum Disorders After Menopause: A Vulnerable Group for RelapseIris E Sommer, Bodyl A Brand, Shiral Gangadin, et al.
Current Psychiatry Reports|October 21, 2023
Evidence-Based Recommendations for the Pharmacological Treatment of Women with Schizophrenia Spectrum DisordersBodyl A Brand, Elske J M Willemse, Iris M H Hamers, et al.
Psychological Medicine|October 19, 2020
Efficacy of non-invasive brain stimulation on cognitive functioning in brain disorders: a meta-analysisMarieke J Begemann, Bodyl A Brand, Branislava Ćurčić-Blake, et al.
Current Psychiatry Reports|July 18, 2024
Correction to: Evidence‑Based Recommendations for the Pharmacological Treatment of Women with Schizophrenia Spectrum DisordersBodyl A Brand, Elske J M Willemse, Iris M H Hamers, et al.
The American Journal of Psychiatry|September 12, 2024
Real-World Effectiveness of Menopausal Hormone Therapy in Preventing Relapse in Women With Schizophrenia or Schizoaffective DisorderBodyl A Brand, Iris E Sommer, Shiral S Gangadin, et al.
BMC Medicine|July 7, 2025
Do women need a change in dose of prescription drugs with onset of menopause? Time to find outIris E C Sommer, Bodyl A Brand, Tanja R Zijp, et al.
Pageof 3